FDA: Mini-study (retesting) [Outliers]

posted by Helmut Homepage – Vienna, Austria, 2014-05-26 19:50 (3645 d 20:46 ago) – Posting: # 13007
Views: 4,404

Dear all,

at the last two conferences in Budapest I discussed the issue of retesting subjects with (former) emplo­yees of the FDA.From time to time people send me data desperately wanting me to “safe” their studies. Sorry folks, there is no free lunch. Observations:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 16:36 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz